Polymorphisms of glutathione S-transferase mu 1, theta 1, and pi 1 genes and prognosis in Hodgkin lymphoma

References

• Diehl V, Franklin J, Pfreundschuh M, et al. Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease. N Engl J Med 2003;348:2386–2395.
   PubMed Web of Science ®Google Scholar
• Bonadonna G, Viviani S, Bonfante V, Gianni AM, Valagussa P. Survival in Hodgkin's disease patients - report of 25 years of experience at the Milan Cancer Institute. Eur J Cancer 2005;41:998–1006.
   PubMed Web of Science ®Google Scholar
• O'Brien ML, Tew KD. Glutathione and related enzymes in multidrug resistance. Eur J Cancer 1996;32A:967–978.
   PubMed Web of Science ®Google Scholar
• O'Brien M, Kruh GD, Tew KD. The influence of coordinate overexpression of glutathione phase II detoxification gene products on drug resistance. J Pharmacol Exp Ther 2000;294:480–487.
   PubMed Web of Science ®Google Scholar
• Goto S, Ihara Y, Urata Y, et al. Doxorubicin-induced DNA intercalation and scavenging by nuclear glutathione S-transferase P1. FASEB J 2001;15:2702–2714.
   PubMed Web of Science ®Google Scholar
• Townsend DM, Tew KD. The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 2003;22:7369–7375.
   PubMed Web of Science ®Google Scholar
• Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol 2005;45:51–88.
   PubMed Web of Science ®Google Scholar
• Lo HW, Ali-Osman F. Genetic polymorphism and function of glutathione S-transferases in tumor drug resistance. Curr Opin Pharmacol 2007;7:367–374.
   PubMed Web of Science ®Google Scholar
• Kellen E, Hemelt M, Broberg K, et al. Pooled analysis and meta-analysis of the glutathione S-transferase P1 Ile 105Val polymorphism and bladder cancer: a HuGE-GSEC review. Am J Epidemiol 2007;165:1221–1230.
   PubMed Web of Science ®Google Scholar
• Zimniak P, Nanduri B, Pikula S, et al. Naturally occurring human glutathione S-transferase GSTP1 isoforms with isoleucine and valine in position 104 differ in enzymatic properties. Eur J Biochem 1994;224:893–899.
   PubMedGoogle Scholar
• Sundberg K, Johansson AS, Stenberg G, et al. Differences in the catalytic efficiencies of allelic variants of glutathione transferase PI-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. Carcinogenesis 1998;19:433–436.
   PubMed Web of Science ®Google Scholar
• Lemos MC, Cabrita FJ, Silva HA, Vivan M, Plácido F, Regateiro FJ. Genetic polymorphism of CYP2D6, GSTM1 and NAT2 and susceptibility to haematological neoplasias. Carcinogenesis 1999;20:1225–1229.
   PubMed Web of Science ®Google Scholar
• Sarmanová J, Benesová K, Gut I, Nedelcheva-Kristensen V, Tynková L, Soucek P. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas. Hum Mol Genet 2001;10:1265–1273.
   PubMed Web of Science ®Google Scholar
• Soucek P, Sarmanová J, Kristensen VN, Apltauerová M, Gut I. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas. Int Arch Occup Environ Health 2002;75:S86–S92.
   PubMed Web of Science ®Google Scholar
• Hohaus S, Massini G, D'Alo' F, et al. Association between glutathione S-transferase genotypes and Hodgkin's lymphoma risk and prognosis. Clin Cancer Res 2003;9:3435–3440.
   PubMed Web of Science ®Google Scholar
• Hohaus S, Di Ruscio A, Di Febo A, et al. Glutathione S-transferase P1 genotype and prognosis in Hodgkin's lymphoma. Clin Cancer Res 2005;11:175–2179.
   Web of Science ®Google Scholar
• Ribrag V, Koscielny S, Casasnovas O, et al. Pharmacogenetic study in Hodgkin's lymphomas reveals the impact of UGT1A1 polymorphisms on patient's prognosis. Blood 2009;113:3307–3313.
   PubMed Web of Science ®Google Scholar
• Duncan BB, Schmidt MI, Polansky CA. High mortality rates among Brazilian adult populations-an international comparison. Rev Assoc Med Bras 1992;38:138–144.
   PubMedGoogle Scholar
• Souza CA, Vassallo J, Lorand-Metze I. Hodgkin's disease in Brazil: a clinical-pathological study. Haematologica 1997;82:127–128.
   PubMed Web of Science ®Google Scholar
• Lourenço GJ, Neri IA, Sforni VCS, Kameo R, Lorand-Metze I, Lima CSP. Polymorphisms of glutathione S-transferase Mu 1, glutathione S-transferase theta 1 and glutathione S-transferase Pi 1 genes in Hodgkin's lymphoma susceptibility and progression. Leuk Lymphoma 2009;50:1005–1009.
   PubMed Web of Science ®Google Scholar
• Stein H. Hodgkin lymphoma. In: Swerdlow S, Camp E, Harris N, et al., editors. WHO classification of tumors of haematopoietic and lymphoid tissues. Lyon: IARC; 2008. pp.
   Google Scholar
• Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee of Hodgkin's Disease Staging Classification. Cancer Res 1971;31:1860–1861.
   PubMed Web of Science ®Google Scholar
• Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. N Engl J Med 1998;339:1506–1514.
   PubMed Web of Science ®Google Scholar
• Comstock KE, Sanderson BJS, Clafin G, Hener WD. GST1 gene deletion determined by polymerase chain reaction. Nucleic Acids Res 1990;18:3670–3676.
   PubMed Web of Science ®Google Scholar
• Pemble S, Schroeder KR, Spencer SR, et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 1994;300:271–276.
   PubMed Web of Science ®Google Scholar
• Irazusta SP, Vassallo J, Magna LA, Metze K, Trevisan M. The value of PCNA and AgNOR staining in endoscopic biopsies of gastric mucosa. Pathol Res Pract 1998;194:33–39.
   PubMed Web of Science ®Google Scholar
• Cia EM, Trevisan M, Metze K. Argyrophilic nucleolar organizer region (AgNOR) technique: a helpful tool for differential diagnosis in urinary cytology. Cytopathology 1999;10:30–39.
   PubMed Web of Science ®Google Scholar
• Lorand-Metze I, Pinheiro MP, Ribeiro E, de Paula EV, Metze K. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications. Leuk Res 2004;28:587–594.
   PubMed Web of Science ®Google Scholar
• Bedin V, Adam RL, Sá BCS, Landman G, Metze K. Fractal dimension is an independent prognostic factor for survival in melanoma. BMC Cancer 2010;10:260.
   PubMed Web of Science ®Google Scholar
• Lorand-Metze I, Pinheiro MP, Ribeiro E, de Paula EV, Metze K. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications. Leuk Res 2004;28:587–594.
   PubMed Web of Science ®Google Scholar
• Engert A. Aktuelle Therapiestrategien der Deutschen Hodgkin Studiengruppe. Onkologe 2010;16:28–34.
   Web of Science ®Google Scholar
• Han X, Zheng T, Foss FM, et al. Genetic polymorphisms in the metabolic pathway and non-Hodgkin lymphoma survival. Am J Hematol 2010;85:51–56.
   PubMed Web of Science ®Google Scholar
• Dieckvoss BO, Stanulla M, Schrappe M, et al. Polymorphisms within glutathione S-transferase genes in pediatric non-Hodgkin's lymphoma. Haematologica 2002;87:709–713.
   PubMed Web of Science ®Google Scholar
• Daly AK. Drug-induced liver injury: past, present and future. Pharmacogenomics 2010;11:607–611.
   PubMed Web of Science ®Google Scholar
• Gilliland FD, Li Y-F, Saxon A, Diaz-Sanchez D. Effect of glutathione-S-transferase M1 and P1 genotypes on xenobiotic enhancement of allergic responses: randomized, placebo-controlled crossover study. Lancet 2004;363:119–125.
   PubMed Web of Science ®Google Scholar
• Küppers R. B cells under influence: transformation of B-cells by Epstein-Barr virus. Nat Rev Immunol 2003;3:801–812.
   PubMed Web of Science ®Google Scholar